about
Decreased Frequency of Circulating Myelin Oligodendrocyte Glycoprotein B Lymphocytes in Patients with Relapsing-Remitting Multiple Sclerosis.Evaluation of the role of human herpes virus 6 and 8 in parapsoriasis.Emergence of HCV resistance-associated variants in patients failing sofosbuvir-based regimens: an observational cohort.Detection of herpes simplex virus (1 and 2), varicella-zoster virus, cytomegalovirus, human herpesvirus 6 and enterovirus in immunocompetent Tunisian patients with acute neuromeningeal disorder.Lytic EBV infection investigated by detection of Soluble Epstein-Barr virus ZEBRA in the serum of patients with PTLD.An NS5A single optimized method to determine genotype, subtype and resistance profiles of Hepatitis C strains.Impact of stem cell graft on early viral infections and immune reconstitution after allogeneic transplantation in adults.Severe Symptomatic Primary Human Cytomegalovirus Infection despite Effective Innate and Adaptive Immune Responses.Human herpesvirus (HHV)-6 and HHV-7: two closely related viruses with different infection profiles in stem cell transplantation recipients.Modulation of HLA-A*0201-restricted T cell responses by natural polymorphism in the IE1(315-324) epitope of human cytomegalovirus.Long-lasting HHV-6 reactivation in long-term adult survivors after double umbilical cord blood allogeneic stem cell transplantation.Quantification of two viral transcripts by real time PCR to investigate human herpesvirus type 6 active infection.A FUT2 gene common polymorphism determines resistance to rotavirus A of the P[8] genotype.Amplified NKG2C+ NK cells in cytomegalovirus (CMV) infection preferentially express killer cell Ig-like receptor 2DL: functional impact in controlling CMV-infected dendritic cells.Genotyping and resistance profile of hepatitis C (HCV) genotypes 1-6 by sequencing the NS3 protease region using a single optimized sensitive method.Evaluation of the presence of equine viral herpesvirus 1 (EHV-1) and equine viral herpesvirus 4 (EHV-4) DNA in stallion semen using polymerase chain reaction (PCR).Characterization of various blood and graft sources: a prospective series.Cellular normalization of viral DNA loads on whole blood improves the clinical management of cytomegalovirus or Epstein Barr virus infections in the setting of pre-emptive therapy.Resistance pattern of cytomegalovirus (CMV) after oral valganciclovir therapy in transplant recipients at high-risk for CMV infection.
P50
Q35674246-EBD1C28A-7067-4831-BBB9-55C334069AE7Q38424935-DCCF59AF-8FEE-4F3A-AA38-F9C78CC3DDB5Q38875499-40A5A36D-3CD9-4A8B-BDA6-5A144C8CB0EEQ39290866-AC7E21C7-B9D6-43A8-9E7A-94797F63C9DCQ40056807-155D5235-5BF6-4DAC-B5C8-ECC3CF72F5D7Q40114959-B990052E-C939-4CFD-A554-340E503D50E5Q40164780-84D3477E-3DDC-4862-AE9D-391938F71B51Q40392303-5F025740-F85A-498E-AD97-CC7088F90E2AQ40566639-E7E54DFC-B0E0-4E29-85B8-C0BC03892A6DQ40671945-2908E584-8EC8-4E13-8BBE-28F3D34558D6Q42233684-8B5951A3-9E3C-46B2-B98E-B02EA6729FB7Q42245900-D11BF567-0082-44FA-B95E-ED4EAE382678Q42252977-4040DE06-4752-4522-A7E7-6184E2A01756Q42278749-5D84189B-72DE-4180-9221-DA8FDA0E9F6BQ42981631-8E90C87D-2288-492E-B8CB-B8254A96F423Q43368195-539A054E-0B7F-4A37-BF34-0C86FCD40885Q44018586-9F74C2B4-81B6-4F46-88F5-AC3958F31554Q45388439-E34C394D-DCC5-46BF-8D55-E5D812F676F7Q46209853-67399721-083F-4009-86A5-42B90E711893
P50
name
Berthe-Marie Imbert-Marcille
@ast
Berthe-Marie Imbert-Marcille
@en
Berthe-Marie Imbert-Marcille
@es
Berthe-Marie Imbert-Marcille
@nl
type
label
Berthe-Marie Imbert-Marcille
@ast
Berthe-Marie Imbert-Marcille
@en
Berthe-Marie Imbert-Marcille
@es
Berthe-Marie Imbert-Marcille
@nl
prefLabel
Berthe-Marie Imbert-Marcille
@ast
Berthe-Marie Imbert-Marcille
@en
Berthe-Marie Imbert-Marcille
@es
Berthe-Marie Imbert-Marcille
@nl